{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T06:18:23Z","timestamp":1787811503889,"version":"build-2784847793"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Cystic fibrosis (CF) is a multisystem disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Allergic bronchopulmonary aspergillosis (ABPA) is a recognized complication in CF, with genetic variability potentially influencing susceptibility. This study aims to assess the distribution of CFTR genotype classes in CF patients with ABPA and explore their association with disease severity and baseline pulmonary function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cross-sectional study was conducted over a 10-year period, including patients &amp;lt;18 years with genetically confirmed CF and concomitant ABPA. CFTR mutation data were analyzed, and comparative analyses were performed across CFTR genotype classes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-two patients were included, with a median age of 13.75 years at the time of ABPA diagnosis. CFTR mutations identified were predominantly classified as Class I (72.7%), followed by Class II (22.7%), with a single patient harboring a Class V mutation. Patients with Class II\/V mutations showed lower growth indices and baseline pulmonary function compared to Class I, without statistical significance (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;gt;\u20090.05). Chest CT findings were comparable between the groups, with bronchiectasis and bronchial wall thickening representing the most common radiological abnormalities.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CFTR genotype may influence clinical phenotype in CF patients with ABPA, with trends toward poorer growth and lung function in more severe mutation classes, although larger studies are needed to confirm these associations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1938948","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:34:38Z","timestamp":1787808878000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CFTR mutations and genotypic patterns among cystic fibrosis patients with allergic bronchopulmonary aspergillosis: analysis from a tertiary care center in Saudi Arabia"],"prefix":"10.3389","volume":"14","author":[{"given":"Maryam Fuad","family":"Ali","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Arabian Gulf University","place":["Manama, Bahrain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hessa","family":"AlOtaibi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, King Fahad Specialist Hospital","place":["Dammam, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"AlZahrani","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, King Faisal Hospital and Research Centre","place":["Medina, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Hafez","sequence":"additional","affiliation":[{"name":"Al Faisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Khokhar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hamad Medical Corporation","place":["Doha, Qatar"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maad","family":"Jalal","sequence":"additional","affiliation":[{"name":"Yale Biomedical Imaging Institute","place":["New Haven, CT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Albalawi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, King Faisal Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad","family":"AlHuthil","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, King Faisal Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Banjar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, King Faisal Hospital and Research Centre","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/jof10090656","article-title":"Allergic bronchopulmonary aspergillosis (ABPA) in the era of cystic fibrosis transmembrane conductance regulator (CFTR) modulators","volume":"10","author":"Chatterjee","year":"2024","journal-title":"J Fungi"},{"key":"B2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.aller.2010.06.002","article-title":"Cystic fibrosis, atopy, asthma and ABPA","volume":"38","author":"Antunes","year":"2010","journal-title":"Allergol Immunopathol (Madr)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.24911\/IJMDC.51-1672401472","article-title":"Prevalence and diagnosis of allergic bronchopulmonary aspergillosis: a systematic review","volume":"7","author":"Hadal","year":"2023","journal-title":"IJMDC"},{"key":"B4","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaip.2022.12.012","article-title":"Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis","volume":"11","author":"Jin","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B5","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1439-0507.2011.02130.x","article-title":"Link between CFTR mutations and ABPA: a systematic review and meta-analysis","volume":"55","author":"Agarwal","year":"2012","journal-title":"Mycoses"},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5144\/0256-4947.2020.15","article-title":"Genotype patterns for mutations of the cystic fibrosis transmembrane conductance regulator gene: a retrospective descriptive study from Saudi Arabia","volume":"40","author":"Banjar","year":"2020","journal-title":"Ann Saudi Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2400061","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur Respir J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"B9","first-page":"45","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis","volume":"59","author":"Miller","year":"1996","journal-title":"Am J Hum Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3390\/jof11020116","article-title":"Longitudinal study on clinical predictors for allergic bronchopulmonary aspergillosis in children and young people with cystic fibrosis highlights the impact of infection with Aspergillus and Pseudomonas and ivacaftor treatment","volume":"11","author":"Chesshyre","year":"2025","journal-title":"J Fungi"},{"key":"B11","doi-asserted-by":"publisher","first-page":"101326","DOI":"10.1016\/j.mycmed.2022.101326","article-title":"Frequencies of pathogenic CFTR variants in Greek cystic fibrosis patients with allergic bronchopulmonary aspergillosis and Aspergillus fumigatus chronic colonization: a retrospective cohort study","volume":"33","author":"Noni","year":"2023","journal-title":"J Mycol Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"678374","DOI":"10.3389\/fgene.2021.678374","article-title":"Ethnic differences in the frequency of CFTR gene mutations in populations of the European and North Caucasian part of the Russian federation","volume":"12","author":"Petrova","year":"2021","journal-title":"Front Genet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1034\/j.1399-3003.2000.016003464.x","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic registry of cystic fibrosis","volume":"16","author":"Mastella","year":"2000","journal-title":"Eur Respir J"},{"key":"B14","doi-asserted-by":"publisher","first-page":"myaf030","DOI":"10.1093\/mmy\/myaf030","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis: case-control study from the French registry","volume":"63","author":"Tarizzo","year":"2025","journal-title":"Med Mycol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1938948\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:34:38Z","timestamp":1787808878000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1938948\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":14,"alternative-id":["10.3389\/fped.2026.1938948"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1938948","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1938948"}}